BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35900318)

  • 1. Circular RNAs: novel regulators of resistance to systemic treatments in breast cancer.
    Guo XQ; Hua YM
    Neoplasma; 2022 Sep; 69(5):1019-1028. PubMed ID: 35900318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. circRNAs in drug resistance of breast cancer.
    Misir S; Yaman SO; Petrović N; Sumer C; Hepokur C; Aliyazicioglu Y
    Oncol Res; 2022; 30(4):157-172. PubMed ID: 37304411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNAs in Breast Cancer: An Update.
    Bao H; Li J; Zhao Q; Yang Q; Xu Y
    Biomolecules; 2024 Jan; 14(2):. PubMed ID: 38397395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA; a new biomarker for breast cancer: A systematic review.
    Jahani S; Nazeri E; Majidzadeh-A K; Jahani M; Esmaeili R
    J Cell Physiol; 2020 Jul; 235(7-8):5501-5510. PubMed ID: 31985056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression.
    Liang G; Ling Y; Mehrpour M; Saw PE; Liu Z; Tan W; Tian Z; Zhong W; Lin W; Luo Q; Lin Q; Li Q; Zhou Y; Hamai A; Codogno P; Li J; Song E; Gong C
    Mol Cancer; 2020 Mar; 19(1):65. PubMed ID: 32213200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spotlight on Exosomal Non-Coding RNAs in Breast Cancer: An In Silico Analysis to Identify Potential lncRNA/circRNA-miRNA-Target Axis.
    Ashekyan O; Abdallah S; Shoukari AA; Chamandi G; Choubassy H; Itani ARS; Alwan N; Nasr R
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unearthing Regulatory Axes of Breast Cancer circRNAs Networks to Find Novel Targets and Fathom Pivotal Mechanisms.
    Afzali F; Salimi M
    Interdiscip Sci; 2019 Dec; 11(4):711-722. PubMed ID: 31187432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. circRNAs and their relationship with breast cancer: a review.
    Zhang F; Li L; Fan Z
    World J Surg Oncol; 2022 Nov; 20(1):373. PubMed ID: 36443878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
    Zang H; Li Y; Zhang X; Huang G
    Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA and its potential diagnostic and therapeutic values in breast cancer.
    Gao D; Cui C; Jiao Y; Zhang H; Li M; Wang J; Sheng X
    Mol Biol Rep; 2024 Feb; 51(1):258. PubMed ID: 38302635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNAs in the tumour microenvironment.
    Ma Z; Shuai Y; Gao X; Wen X; Ji J
    Mol Cancer; 2020 Jan; 19(1):8. PubMed ID: 31937318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospect of exosomal circular RNAs in breast Cancer: presents and future.
    Zokaei E; Darbeheshti F; Rezaei N
    Mol Biol Rep; 2022 Jul; 49(7):6997-7011. PubMed ID: 35534582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis and validation of m6A regulatory network: a novel circBACH2/has-miR-944/HNRNPC axis in breast cancer progression.
    Lv W; Tan Y; Xiong M; Zhao C; Wang Y; Wu M; Wu Y; Zhang Q
    J Transl Med; 2021 Dec; 19(1):527. PubMed ID: 34952600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling and integrated analysis of differentially expressed circRNAs as novel biomarkers for breast cancer.
    Li Z; Chen Z; Hu G; Zhang Y; Feng Y; Jiang Y; Wang J
    J Cell Physiol; 2020 Nov; 235(11):7945-7959. PubMed ID: 31943203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA hsa_circ_0000376 Participates in Tumorigenesis of Breast Cancer by Targeting miR-1285-3p.
    Peng Z; Xu B; Jin F
    Technol Cancer Res Treat; 2020; 19():1533033820928471. PubMed ID: 32462972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
    Xu JH; Wang Y; Xu D
    Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA FAT atypical cadherin 1 (circFAT1)/microRNA-525-5p/spindle and kinetochore-associated complex subunit 1 (SKA1) axis regulates oxaliplatin resistance in breast cancer by activating the notch and Wnt signaling pathway.
    Yao Y; Li X; Cheng L; Wu X; Wu B
    Bioengineered; 2021 Dec; 12(1):4032-4043. PubMed ID: 34288822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA OMA1 regulates the progression of breast cancer via modulation of the miR‑1276/SIRT4 axis.
    Xu L; Xu K; Xiang L; Yan J
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34414449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current evidence on circRNAs as potential theranostic markers for detecting chemoresistance in breast cancer: a systematic review and meta‑analysis.
    Zhu Z; Jiang H; Xie J; Jin X; Li B; Liu J
    Sci Rep; 2022 Dec; 12(1):22016. PubMed ID: 36539545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNAs Interaction with MiRNAs: Emerging Roles in Breast Cancer.
    Gong L; Zhou X; Sun J
    Int J Med Sci; 2021; 18(14):3182-3196. PubMed ID: 34400888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.